An Open Label 100 Person Study Evaluating a Natural Supplement for Weight Loss and Fat Loss.
NCT07152470 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-09-09
Summary
The goal of this clinical trial is to learn if motus, a natural supplement can support healthy weight loss and fat loss in a real world setting without caloric restrictions or exercise requirements.
The main questions it aims to answer are:
Can a daily dose of motus result in statistically significant weight loss over 3 month and 6 month time points.
Participants will:
Weigh-in at baseline and every week thereafter Take drug motus every day Complete a food tracker app for every meal and drink product consumed daily Complete an exercise tracker for any activities performed daily Complete weekly satisfaction surveys on various topics
Conditions
- Overweight and Obesity
Interventions
- BEHAVIORAL
-
Diet and Exercise Tracking
To determine if diet and/or exercise had any impact on weight loss while taking motus.
Sponsors & Collaborators
-
Prostasis, LLC, dba Tonum Health
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-26
- Primary Completion
- 2025-07-26
- Completion
- 2025-12-26
Countries
- United States
Study Locations
More Related Trials
-
Safety and Effectiveness Study of a Fiber Supplement for Weight Loss
NCT00613600 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Zenoctil in Reducing Body Weight
NCT01423617 ·Status: COMPLETED ·Phase: PHASE3
-
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
NCT00748605 ·Status: COMPLETED ·Phase: PHASE2
-
β-hydroxy-β-methylbutyrate-enriched Nutritional Supplements for Obesity Adults
NCT04953936 ·Status: UNKNOWN ·Phase: NA
-
A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety
NCT00735683 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Pharmacological Stimulation of BAT and WAT in Lean and Obese Young Adults
NCT02354807 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Obex in Overweight and Obese Patients
NCT02145442 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of LAPS-Exendin on Body Weight in Obese Population
NCT02075281 ·Status: COMPLETED ·Phase: PHASE2
-
Benefit and Tolerability of IQP-AE-103 in Weight Loss
NCT03058367 ·Status: COMPLETED ·Phase: NA
-
A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults
NCT04116632 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs
NCT00494767 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of IQP- AK-102 in Reducing Body Weight
NCT01905956 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
NCT04707313 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Obex® in Overweight and Obesity
NCT03541005 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Consumption of Pep19 on Quality of Life
NCT06359327 ·Status: COMPLETED ·Phase: NA
-
A Study Investigating the Effects of Activamp on Body Weight, Fat Loss, and Metabolic Markers in Healthy Overweight Participants
NCT02188251 ·Status: COMPLETED ·Phase: PHASE2
-
"Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat
NCT00377975 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Benefit of ProbioSatys™ on Weight Reduction in Overweight Subjects
NCT03657186 ·Status: COMPLETED ·Phase: NA
-
Effect of Momordica Charantia Administration on Anthropometric Indicators in Patients With Obesity
NCT04916379 ·Status: UNKNOWN ·Phase: NA
-
Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects
NCT00909766 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
NCT00537420 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of ZT006 in Overweight and Obese Participants
NCT07230132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker
NCT04408586 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects
NCT01597609 ·Status: COMPLETED ·Phase: PHASE1
-
B181 Metobes-III: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)
NCT00302263 ·Status: COMPLETED ·Phase: PHASE2/PHASE3